San Diego-based mostly Viking Therapeutics marked by itself as a significant competitor while in the weight loss drug marketplace in February right after revealing promising details from the mid-phase demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As well as